Victory Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.3M | Sell |
|
|||||
|
2025
Q2 | $91.3M | Buy |
|
|||||
|
2025
Q1 | $61.6M | Sell |
|
|||||
|
2024
Q4 | $99.6M | Buy |
|
|||||
|
2024
Q3 | $102M | Sell |
|
|||||
|
2024
Q2 | $104M | Sell |
|
|||||
|
2024
Q1 | $95.4M | Buy |
|
|||||
|
2023
Q4 | $81.6M | Buy |
|
|||||
|
2023
Q3 | $73.2M | Buy |
|
|||||
|
2023
Q2 | $55.7M | Sell |
|
|||||
|
2023
Q1 | $94.2M | Buy |
|
|||||
|
2022
Q4 | $65.1M | Sell |
|
|||||
|
2022
Q3 | $63.4M | Buy |
|
|||||
|
2022
Q2 | $45.7M | Sell |
|
|||||
|
2022
Q1 | $61.5M | Buy |
|
|||||
|
2021
Q4 | $57.5M | Buy |
|
|||||
|
2021
Q3 | $53.2M | Buy |
|
|||||
|
2021
Q2 | $47M | Buy |
|
|||||
|
2021
Q1 | $39.3M | Sell |
|
|||||
|
2020
Q4 | $42.1M | Buy |
|
|||||
|
2020
Q3 | $47.7M | Buy |
|
|||||
|
2020
Q2 | $51.2M | Sell |
|
|||||
|
2020
Q1 | $74.5M | Buy |
|
|||||
|
2019
Q4 | $31.6M | Buy |
|
|||||
|
2019
Q3 | $16.4M | Buy |
|
|||||
|
2019
Q2 | $2.49M | Buy |
|
|||||
|
2019
Q1 | $3.25M | Sell |
|
|||||
|
2018
Q4 | $3.27M | Sell |
|
|||||
|
2018
Q3 | $3.55M | Buy |
|
|||||
|
2018
Q2 | $2.92M | Buy |
|
|||||
|
2018
Q1 | $2.63M | Buy |
|
|||||
|
2017
Q4 | $1.44M | Buy |
|
|||||
|
2017
Q3 | $1.61M | Sell |
|
|||||
|
2017
Q2 | $1.95M | Buy |
|
|||||
|
2017
Q1 | $1.38M | Buy |
|
|||||
|
2016
Q4 | $1.05M | Buy |
|
|||||
|
2016
Q3 | $1.1M | Buy |
|
|||||
|
2016
Q2 | $821K | Buy |
|
|||||
|
2016
Q1 | $832K | Buy |
|
|||||
|
2015
Q4 | $1.13M | Buy |
|
|||||
|
2015
Q3 | $467K | Sell |
|
|||||
|
2015
Q2 | $541K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $17K | Buy |
|